Gabon vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Gabon
3.2%
in 2024
Syrian Arab Republic
2.9%
in 2024
Gabon rank
3rd
Syrian Arab Republic rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Gabon
- Syrian Arab Republic
How they compare
Gabon currently reports 3.2% against 2.9% in Syrian Arab Republic, a difference of 0.3%.
That makes Gabon's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Gabon ahead.
Gabon ranks 3rd and Syrian Arab Republic ranks 6th of 246 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gabon | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.9% | 3.5% | 0.5% | Syrian Arab Republic |
| 2020s | 3.1% | 3.4% | 0.3% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Gabon or Syrian Arab Republic?
- Gabon, at 3.2% against 2.9% in Syrian Arab Republic as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Gabon and Syrian Arab Republic?
- 0.3%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Gabon and Syrian Arab Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Gabon ranks 3rd and Syrian Arab Republic ranks 6th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.